# Replication of the ISAR-REACT 5 Antiplatelet Trial in Healthcare Claims Data

> **NCT05086081** · — · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 28389 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** Ticagrelor 90mg
- **DRUG:** Prasugrel 10mg

## Key facts

- **NCT ID:** NCT05086081
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-10
- **Primary completion:** 2021-09-10
- **Final completion:** 2021-09-10
- **Target enrollment:** 28389 (ACTUAL)
- **Last updated:** 2023-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05086081

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05086081, "Replication of the ISAR-REACT 5 Antiplatelet Trial in Healthcare Claims Data". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05086081. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*